Olema Pharmaceuticals, Inc. Common Stock OLMA
$7.82
+0.00%
at last close
Market Cap$684.23 million
P/E Ratio—
Div Yield—
Volume758.3K
52-Week Range
$6.65$36.26
Analyst Ratings
- Consensus
- Buy — 10 Buy · 1 Hold · 0 Sell (11 analysts)
- Avg. Price Target
- $40.67 (+420.0% upside)
Key Stats
- Today's Range
- $7.72 – $8.00
- 50-Day Range
- $7.56 – $12.21
- 52-Week Range
- $6.65 – $36.26
- Volume
- 758K shs
- Average Volume
- 1.17 million shs
- Market Cap
- $684.23 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.50%
- Days to Cover
- 1.05
About Olema Pharmaceuticals, Inc. Common Stock
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Related Stocks
Compare head-to-head: OLMA vs LLY·OLMA vs JNJ·OLMA vs ABBV·OLMA vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.